PT141 (10MG)

Description

PT-141 (Bremelanotide) – Research Peptide Compound (10 mg)

PT-141, also known as Bremelanotide, is a synthetic melanocortin peptide analog derived from α-melanocyte-stimulating hormone (α-MSH). It is widely utilized in neuropeptide and receptor-binding research, particularly in studies involving melanocortin receptor pathways and central nervous system signaling mechanisms.

PT-141 features a modified peptide sequence designed to enhance molecular stability and receptor selectivity. Due to its defined structure and high purity profile, it is commonly selected for structure–activity relationship (SAR) studies and advanced biochemical research applications.

Chemical & Molecular Information

• Compound Name: PT-141 (Bremelanotide)

• PubChem CID: 9941379

• Peptide Sequence: Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-OH

• Peptide Class: Melanocortin receptor agonist

• Form: Lyophilized peptide powder

• Strength: 10 mg per vial

Research Applications

PT-141 is investigated in laboratory and analytical settings for:

• Melanocortin receptor signaling studies

• Neuropeptide–receptor interaction research

• Central nervous system pathway analysis

• Peptide binding affinity and selectivity models

• Structure–activity relationship (SAR) research

Its reproducible molecular profile makes it suitable for controlled experimental use by qualified professionals.

Quality & Analytical Data

• Purity: 99.85%

• Analytical Method: HPLC-UV-MS

• Verification: Confirmed primary peak at 99.85% purity

• Manufactured & Tested By: MZ Biolabs

• Lot Number: JN-334

Note: Injectable peptide formulations may contain salts or buffering agents to support solubility and pH stability. These components are not detected via UV analysis and are not classified as impurities.

Packaging & Handling

• Supplied in sealed, sterile research vials

• Intended for laboratory research environments

• Store according to professional peptide handling standards